Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C

Authors

  • Alejandro Soza M.D.,

    1. Liver Diseases Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
    Search for more papers by this author
  • Jay H. Hoofnagle M.D.

    1. Liver Diseases Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
    Search for more papers by this author

No abstract is available for this article.

Ancillary